A Study of LY900014 Formulation at Different Injection Sites in Healthy Participants
Clinical trial NCT03232983 · COMPLETED
Trial details
- NCT number
- NCT03232983
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-14
- Primary completion
- 2017-11-09
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.